Stallergenes Greer Revenue and Competitors
Estimated Revenue & Valuation
- Stallergenes Greer's estimated annual revenue is currently $263.3M per year.
- Stallergenes Greer's estimated revenue per employee is $201,000
Employee Data
- Stallergenes Greer has 1310 Employees.
- Stallergenes Greer grew their employee count by 6% last year.
Stallergenes Greer's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Commercial Officer | Reveal Email/Phone |
3 | CFO | Reveal Email/Phone |
4 | VP Global Marketing, Competitive Intelligence, SFE | Reveal Email/Phone |
5 | VP Regulatory Affairs Americas | Reveal Email/Phone |
6 | Head Business Development | Reveal Email/Phone |
7 | VP Corporate Social Responsibility | Reveal Email/Phone |
8 | Head Site Controlling | Reveal Email/Phone |
9 | Head Marketing | Reveal Email/Phone |
10 | VP, Human SCIT & Animal Health | Reveal Email/Phone |
Stallergenes Greer Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $64.5M | 321 | 10% | N/A | N/A |
#2 | $25.5M | 127 | 5% | N/A | N/A |
#3 | $115.6M | 575 | 2% | N/A | N/A |
#4 | $21.7M | 108 | 4% | N/A | N/A |
#5 | $44.8M | 223 | 9% | N/A | N/A |
#6 | $15.1M | 75 | -67% | N/A | N/A |
#7 | $16.1M | N/A | N/A | N/A | |
#8 | $84.4M | 420 | 0% | N/A | N/A |
#9 | $8.8M | 44 | 10% | N/A | N/A |
#10 | $31M | 154 | 28% | N/A | N/A |
What Is Stallergenes Greer?
Stallergenes Greer is a global biopharmaceutical company specialising in the diagnosis and treatment of respiratory allergies through the development and commercialization of Allergy Immunotherapy products and services. \n\nOur purpose is to enable precision medicine to improve life for people with allergies. \n\nWith more than 1,100 employees worldwide, a presence in 40 countries, and manufacturing facilities in both Europe and the United States, Stallergenes Greer Ltd is the parent company of GREER Laboratories, Inc. (whose registered office is in the U.S.) and Stallergenes S.A.S. (whose registered office is in France). \n\nWith complementary strengths, joint heritage and reputations, Stallergenes Greer is driving a continuing leadership in allergy immunotherapy.
keywords:N/A
N/A
Total Funding
1310
Number of Employees
$263.3M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Stallergenes Greer News
Stallergenes Greer; Merck; Allergy Therapeutics; Hal-Allergy; ALK-Abello. Global market segmentation Sublingual Allergy Immunotherapy : Sublingual Allergy...
... Key companies covered as a part of this study include Stallergenes Greer, ALK-Abello A/S, Allergy Therapeutics, Allergopharma,...
ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, WOLW Pharma, Holister Stier, Leti.
Other Companies in London
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $416.3M | 1310 | 6% | N/A |
#2 | $497.1M | 1315 | 6% | N/A |
#3 | $268.6M | 1323 | 1% | N/A |
#4 | $75M | 1326 | N/A | N/A |
#5 | $269.4M | 1327 | 53% | $3.6M |